World’s first DNA based COVID-19 vaccine ZyCoV-D receives Emergency Use Authorization (EUA)

The 3 dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from disease as well as viral clearance.

Original source: https://health.economictimes.indiatimes.com/news/pharma/85492977?utm_source=RSS&utm_medium=ETRSS

Related Posts